Key result
Atenolol pre-treatment significantly reduced malondialdehyde levels in heart tissue and tumor necrosis factor-alpha levels in plasma compared to saline (p=0.001).
Why the study?
Does atenolol reduce myocardial injury in a rat model of intestinal ischemia-reperfusion?
Does atenolol reduce myocardial injury in a rat model of intestinal ischemia-reperfusion?
Atenolol pretreatment significantly reduces cardiac damage, oxidative stress, and inflammation in a rat model of intestinal ischemia-reperfusion.
Answers are grounded in this paper and cite their sources.
Atenolol may attenuate cardiac oxidative stress and inflammation; hypothesis-generating in animals, clinical translation untested.
PURPOSE: To investigate the effects of atenolol in inflammatory mediator and oxidative stress in a myocardial injury by intestinal ischemia/reperfusion in rat model. METHODS: Adult Wistar male rats were randomly (n=8), anesthetized and divided in: Sham: submitted to operation only; group SS+IR: intravenous saline infusion following superior mesenteric artery occlusion during 60 minutes (ischemia) and open for 120 minutes (reperfusion); group AT+IR: intravenous atenolol infusion (2 mg/kg) following superior mesenteric artery occlusion during 60 minutes (ischemia) and open for 120 minutes (reperfusion); and group AT+I+AT+R: intravenous atenolol infusion following superior mesenteric artery occlusion during 60 minutes (ischemia) and in the time 45 minutes other atenolol doses were administrated and the artery was open for 120 minutes (reperfusion), all animals were submitted to muscular relaxation for mechanical ventilation. In the end of experiment the animals were euthanized and the hearts tissue were morphology analyzed by histology and malondialdehyde by ELISA, and the plasma were analyzed for tumor necrosis factor-alpha by ELISA. RESULTS: The group SS+IR demonstrated the higher malondialdehyde levels when compared with the atenolol treated-groups (p=0.001) in the heart tissue. The tumor necrosis factor-alpha level in plasma decrease in the treated groups when compared with SS+IR group (p=0.001). Histology analyses demonstrate pyknosis, edema, cellular vacuolization, presence of inflammatory infiltrate and band contraction in the heart tissue of the rats. CONCLUSION: Atenolol significantly reduce the degree of cardiac damage after intestinal ischemia-reperfusion.
No takes yet. Share an insight, caveat, or question.
Okada et al. (2017) studied Myocardial injury by intestinal ischemia/reperfusion. Atenolol vs. Intravenous saline infusion (SS+IR) and Sham was evaluated on Malondialdehyde levels in heart tissue and tumor necrosis factor-alpha level in plasma (p=0.001). Atenolol pre-treatment significantly reduced malondialdehyde levels in heart tissue and tumor necrosis factor-alpha levels in plasma compared to saline (p=0.001).
Synapse has enriched 10 related papers. Consider them for comparative context: